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genital bicuspid aortic valve is also the most common
cause of aortic valve disease in patients under 70 years
of age in North America.3-5
Previous reports have documented increased preva-
lence of coarctation of the aorta,6 aortic dissection,7
annuloaortic ectasia,8,9 and spontaneous innominate,
carotid, and vertebral arterial dissections10 in patients
with congenital bicuspid aortic valve disease. In 1972
McKusick11 reported an association between congenital
bicuspid aortic valve and cystic medial necrosis of the
aorta. Although some authors have claimed that aortic
wall changes are mainly the consequence of hydraulic
laws,12,13 others showed that the histologic changes in
patients with congenital bicuspid aortic valve also occur
in the absence of valve stenosis or incompetence.14 The
latter view supports the hypothesis that a common
B icuspid aortic valve is the most common congenitalheart valve abnormality, occurring in 1% to 2% of
the population.1,2 In surgical pathologic studies, con-
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developmental error is responsible for the association
between bicuspid aortic valve and aortic wall abnor-
malities.11
If this hypothesis is correct, one would have to
assume that the pulmonary root is also involved in this
complex abnormality because the aortic and the pul-
monary roots have the same embryologic origin, the
conotruncus. Interestingly, we have recently observed
that the pulmonary autograft tends to dilate in some
patients with bicuspid aortic valve who have dilated
aortic root before the performance of the Ross proce-
dure.15 The purpose of this study was to evaluate the
histologic changes in the ascending aorta and pul-
monary trunk of patients with congenital bicuspid aor-
tic valve.
Material and methods
After appropriate informed consent, 31 samples of ascend-
ing aorta wall and 16 pulmonary trunk wall were collected
from patients who underwent aortic valve replacement.
Twenty patients had congenital bicuspid aortic valve disease
(BAV group), and 11 patients had trileaflet aortic valve dis-
ease (TAV group). In addition, 11 aortic and 10 pulmonary
artery samples were obtained from 15 control subjects who
had normal trileaflet aortic valve and died of a noncardiovas-
cular illness. The control samples were included in the TAV
group because the histologic findings were very similar to
those of patients with TAV disease.
Tissue samples were obtained approximately 1.0 cm distal
to the sinotubular junction in the anterior aspect of the
ascending aorta and/or the main pulmonary artery. They were
fixed in 10% buffered formalin solution. The tissue was
processed for light microscopy, embedded in paraffin blocks,
and sectioned out at 4 microns thickness from each specimen.
Sections were stained with hematoxylin-eosin, elastic-
trichrome (modified elastic Van Gieson), and the Movat pen-
tachrome stains. All histologic specimens were graded with
Movat pentachrome. Each of the sections was evaluated his-
tologically by 2 observers, 1 of them without any knowledge
of the nature of the case. In 5 instances of discrepancy, the
specimens were re-evaluated by both observers and consen-
sus was attained. The histologic evaluation of the media layer
of the arterial wall was based on the presence and degree of
the 5 variables: (1) fibrosis, (2) medionecrosis, (3) cystic
medial necrosis (mucoid material accumulation), (4) changes
in smooth muscle cells orientation, and (5) elastic fragmenta-
tion. Each variable was graded from 1 to 3 according to the
severity of the process when examined at a magnification of
100 or 200 times, with a Leica DMRB microscope (Leica
Mikroskopi & Systeme, Wetz/Ar, Germany). The grades were
determined on the basis of the worst area observed in each
specimen. The criteria for the histologic grading are summa-
rized in the appendix. Those criteria were modified from
Schlatman and Becker16 to allow evaluation of the pulmonary
trunk as well. Because previous studies suggested that these
histologic changes can be age related,16,17 the specimens
were also analyzed according to age groups: group I, 18 to 35
years of age (mean, 27 years), 13 aortas and 10 pulmonary
arteries; group II, 36 to 45 years of age (mean, 40 years), 10
aortas and 7 pulmonary arteries; group III, 46 to 55 years of
age (mean, 51 years), 8 aortas and 4 pulmonary arteries; and
group IV, 56 to 78 years of age (mean, 69 years), 11 aortas
and 5 pulmonary arteries.
The mean age of patients with BAV and TAV disease was
43 ± 12 years and 51 ± 20 years (P = .14) respectively. Of 20
patients with BAV disease, 16 patients had aortic stenosis
(mean gradient, 67 ± 18 mm Hg), and 4 patients had aortic
insufficiency. Of 11 patients with TAV disease, 7 patients had
aortic stenosis (mean gradient, 62 ± 22 mm Hg), and 4
patients had aortic insufficiency.
It has been suggested that hypertension may induce histo-
logic changes both in the ascending aorta17 and in the pul-
monary artery.18,19 For this reason, specimens were consid-
ered to be from hypertensive subjects when at least 1 the
following conditions was fulfilled: (1) history of drug treat-
ment for hypertension; (2) recorded diastolic pressures
greater than 100 mm Hg; and (3) unexplained cardiomegaly
with left ventricle hypertrophy, cardiac weight of more than
350 g in female and 400 g in male autopsy patients,20 with no
observed cardiac or pulmonary abnormality. According to
these criteria 2 of the patients with BAV disease (10%) were
found to be hypertensive, compared with 7 of the patients
with TAV disease (32%; P = .151). None of the patients with
BAV disease had pulmonary hypertension, and only 2 of the
patients with TAV disease had pulmonary hypertension.
Statistical analysis. Continuous variables were presented
as the mean ± SD and were evaluated by 1-way analysis of
variance. Scheffé multiple range t test was used as a post hoc
test to specify differences between groups. Categoric vari-
ables were analyzed by c 2 or Fisher exact test when cell num-
bers were small.
Results
Ascending aorta histologic features. Table I shows
the grades of 5 histologic features in the ascending
aorta of patients with BAV and TAV disease. The sever-
ity of medionecrosis and fibrosis were similar between
the 2 groups, whereas cystic medial necrosis (P =
.001), smooth muscle cell changes (P = .002) and elas-
tic fragmentation (P = .002) were significantly more
severe in BAV than in TAV disease. In the BAV group,
9 patients (45%) had grade 3 histologic features of cys-
tic medial necrosis, smooth muscle cell changes, or
elastic fragmentation, whereas in the TAV group, only
2 patients (9%) had at least 1 grade 3 histologic change.
Fig 1 shows representative samples of the ascending
aorta of BAV and TAV disease.
Pulmonary trunk histologic features. Table II
shows the grades of 5 histologic features in the media
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of the pulmonary trunk in BAV and TAV groups. The
severity of medionecrosis (P = .12) and fibrosis (P =
.12) were similar in BAV and TAV diseases, whereas
cystic medial necrosis (P = .001), smooth muscle cell
changes (P = .04) and elastic fragmentation (P = .01)
were significantly more severe in BAV disease. In the
BAV group, 9 patients (75%) had grade 3 cystic medi-
al necrosis, smooth muscle cell changes, or elastic frag-
mentation in the pulmonary trunk, whereas in the TAV
group only 2 patients (14%) had grade 3 histologic
changes. Fig 2 shows representative samples of pul-
monary trunks in the BAV and TAV groups.
Correlation between age, hypertension, and histo-
logic changes. We could not establish a correlation
between age or hypertension and the 5 histologic fea-
tures, either for the ascending aorta or for the pul-
monary trunk, possibly because of a relatively small
number of specimens.
Correlation between changes in the aorta and pul-
monary artery. We could not establish a correlation
between the degree of changes in the aorta with those in
the pulmonary in either group of patients, except for
cystic medial necrosis. In the BAV and TAV groups,
67% and 81%, respectively, had the same grade of cys-
tic medial necrosis in the ascending aorta and pul-
monary trunk.
Effect of functional status of the aortic valve. The
degree of histologic changes did not correlate with the
functional status of the aortic valve. All pulmonary
valves were normal.
Discussion
The principal finding in this study was that degenera-
tive changes in the ascending aorta and pulmonary trunk
of patients with BAV disease were more severe than in
patients with TAV disease. The difference in severity
was mainly related to cystic medial necrosis, elastic
fragmentation, and smooth muscle cell orientation
changes and not related to fibrosis or medionecrosis.
Previous studies on the histopathologic features of
the ascending aorta described degenerative changes
similar to those identified in the present study in
patients with aortic dissection,7 ascending aorta aneu-
rysms21 and annuloaortic ectasia.22,23 All those clinical
entities, however, may be associated with BAV dis-
ease.24 McKusick11 suggested the association between
BAV disease and cystic medial necrosis in the ascend-
ing aorta. Consistent with those studies, we found that
cystic medial necrosis, elastic fragmentation, and
smooth muscle cell orientation changes were signifi-
cantly more severe in patients with BAV disease than in
patients with TAV disease. Severe degenerative
changes were uncommon in patients with TAV disease
(9%), whereas almost one half of the patients (45%)
with BAV disease had severe degenerative changes in
the ascending aorta. We had the opportunity to examine
the ascending aorta of 5 patients with the Marfan syn-
drome who had undergone an operation because of aor-
tic root aneurysm during the conduction of the present
study. We found that the severity of histologic changes
in the ascending aorta of patients with BAV disease
Table I. Histologic features of the ascending aorta in
patients with diseased bicuspid and tricuspid aortic
valves
Bicuspid Tricuspid 
group group
Histologic features Grades n % n %
Medionecrosis I 14 70 14 64
II 3 15 8 36
III 3 15 0 0
Fibrosis I 14 70 13 59
II 6 30 9 41
III 0 0 0 0
Cystic medial necrosis I 2 10 17 77
II 13 65 3 14
III 5 25 2 9
Cell changes orientation I 8 40 19 86
II 9 45 3 14
III 3 15 0 0
Elastic fragmentation I 5 25 16 73
II 9 45 6 27
III 6 30 0 0
Table II. Histologic features of the pulmonary artery
in patients with diseased bicuspid and tricuspid aortic
valves
Bicuspid Tricuspid 
group group
Histologic features Grades n % n %
Medionecrosis I 5 42 10 71
II 7 58 4 29
III 0 0 0 0
Fibrosis I 5 42 10 71
II 7 58 4 29
III 0 0 0 0
Cystic medial necrosis I 0 0 11 79
II 10 83 2 14
III 2 17 1 7
Cell changes orientation I 2 16 6 43
II 5 42 7 50
III 5 42 1 7
Elastic fragmentation I 0 0 5 36
II 4 33 7 50
III 8 67 2 14
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was somewhere between those of patients with TAV
disease and those with the Marfan syndrome. The latter
ones are at the extreme in the spectrum of degenerative
changes in the ascending aorta.
Controversy exists regarding the impact of aging on
the histologic changes in the ascending aorta.
Schlatman and Becker16 reported on a correlation
between the severity of all histologic changes and
aging. However, of 6 autopsy cases with grade 3 cystic
medial necrosis, 5 cases were in subjects younger than
40 years of age.16 Those investigators made no com-
ment on the morphologic condition of the aortic
valve.16 Savunen and Aho22 did not find a correlation
between age and histologic changes either in annu-
loaortic ectasia or in normal subjects, although they
reported a slight tendency towards more severe changes
in the aortas of older patients. In a morphologic study
of ascending aortic aneurysms, Klima and colleagues21
described that cystic medial necrosis and elastic frag-
mentation were inversely related to age and arterial
hypertension. Other investigators reported on a correla-
tion between severity of medial changes with age and
hypertension.17 We could not demonstrate such corre-
lation either in the BAV or the TAV groups, even for
fibrosis or medionecrosis. In our study, the BAV group
was younger than the TAV group; therefore our aortic
wall findings cannot be attributed simply to the aging
process. We believe some of the discrepancies between
various studies are due to the differences in patient
population, that is, autopsy versus surgical studies. In
Fig 1. A, Histologic features of a transverse section of ascending aorta, from a 54-year-old patient with a normal
trileaflet aortic valve. Note the circumferential arrangement of smooth muscle cells and elastic tissue plates.
Small foci of accumulation of collagen (pale yellow white areas) and changes in the smooth muscle cell orienta-
tion (arrow). There are no intimal changes. (Movat pentachrome stains; original magnification, · 100.) B,
Histologic features of the ascending aorta from a 33-year-old patient with bicuspid aortic valve disease. Note the
significant medial destruction, accumulation of mucoid material (arrow; pool of mucopolysaccharide). There is
marked fragmentation of elastic tissue, and there are large areas of loss of normal medial muscle. (Movat pen-
tachrome stains; original magnification, · 100.)
A B
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studies like ours, the more severe the histopathologic
changes, the earlier the patient is subjected to surgical
treatment.
Except for 1 case reported by McKusick11 in 1972,
the possibility that the pulmonary trunk itself might
also be pathologically involved in patients with BAV
disease has not been raised. In our study we showed
that the pulmonary trunk was more severely affected in
patients with BAV disease than in patients with TAV
disease. We found that only 14% of the subjects with
TAV disease had severe pulmonary trunk degenerative
changes, whereas this occurred in 75% of the patients
with BAV disease. Interestingly, the 2 TAV subjects
with grade 3 changes in the pulmonary artery had
advanced age. This may suggest that the severe
changes that occur in relatively young patients with
BAV disease may also occur with the aging process in
patients with TAV disease.
We were puzzled with our findings in the pulmonary
arterial wall. We believe the explanation may be found
on the fact that both the aortic and the pulmonary roots
have the same embryologic origin, the conotruncus.
Anomalous migration of cells from the neural crest
may be responsible for the combined occurrence of
anomalies of the aortic arch and the media of the
ascending aorta. Previous studies suggested that anom-
alies that occur at different phases of the migration of
the neural crest may account for isolated or combined
defects of the aortic arch, the wall of the ascending
aorta, and the aortic valve.25,26 Therefore it is possible
Fig 2. A, Normal histologic structure of pulmonary trunk from a 42-year-old patient with tricuspid aortic valve
disease. The medial layer shows a greater degree of interruption and fragmentation of elastic tissue plates than is
seen in the aorta. Elastic tissue and smooth muscle cells run circumferentially. Small scattered areas of collagen
(pale yellow) can be seen. The medial thickness is about 50% to 60% of that of a normal aorta. (Movat pen-
tachrome; original magnification, · 100.) B, Histologic structure of pulmonary trunk from a 40-year-old patient
with bicuspid aortic valve disease. Note disorganized media, with large areas of pools of mucopolysaccharides
(arrow; pale blue) and of collagen deposition (pale yellow). There is also smooth muscle cell disorientation and
fragmentation of elastic tissue. (Movat pentachrome; original magnification, · 100.)
A B
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that the pulmonary trunk may also be affected by this
process.
The fact that in our study only 2 patients in the BAV
group had arterial hypertension and none had pul-
monary hypertension would exclude hypertension as an
underlying mechanism for the morphologic changes in
the aorta and pulmonary trunk, a pathophysiologic
mechanism that has been proposed by some investiga-
tors.17-19 The control group with TAV disease who had
no aortic valve disease had similar histologic changes
to those with diseased TAV. This finding suggests that
the hemodynamic disturbances in the blood flow did
not play a major pathophysiologic role as previously
suggested.27 The similarity of the aortic wall histologic
changes in the BAV and Marfan groups suggests that
the mechanism of aortic and pulmonary artery wall
changes in BAV disease could be a primary one and
possibly related to a microfibrillar protein (eg, fibrillin-
1 disorder or extracellular matrix).
Clinical implications. This study shows that patients
with BAV disease are more likely to experience the
development of degenerative changes in the aorta and
in the pulmonary trunk than patients with TAV disease.
These degenerative changes may be as severe as those
seen in some patients with the Marfan syndrome. It is
probable that these changes greatly reduce the cohesive
and the tensile strength of the media.28 These findings
explain the relatively high incidence of dilation of the
aortic root and ascending aorta and aortic dissections in
patients with BAV disease.7-9 They also justify a surgical-
ly more aggressive approach when treating patients with
BAV disease and dilated aortic root/ascending aorta.
We have recently detected an increased incidence of
pulmonary autograft dilation in patients with BAV dis-
ease who underwent the Ross procedure.15 We believe
that the dilation of the pulmonary autograft is related to
the histopathologic nature and possibly degenerative
changes in the pulmonary trunk as described in this
study. We proposed that pulmonary autograft should be
implanted with the use of the aortic root technique
instead of aortic root replacement in patients with BAV
disease. In addition, both the aortic anulus and the sino-
tubular junction should be fixed with a strip of Dacron
fabric.
Limitations of this study. The principal limitation of
this study is its sample size. Degenerative changes in
the arterial wall of the aorta and pulmonary artery are
complex and variable process. With the current tech-
niques to assess degenerative changes, a prohibitively
high number of arterial wall samples is required to
determine the extent of this problem and its correlation
with various clinical entities. Another limitation is that
we examined histologically only a small segment of
ascending aorta and pulmonary artery.
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Appendix
Criteria for histologic classification of the aorta and
pulmonary artery (modified from Schlatman TJM, Becker
AE. Histologic changes in the normal aging aorta: impli-
cations for dissecting aortic aneurysm. Am J Cardiol
1977;39:13-20)
Fibrosis. Defined as an increase in interstitial collagen.
Sections were examined at a magnification of · 100 times.
Three grades were recognized: grade 1, an increase in colla-
gen content in an area comprising less than one third of the
total width of the media or focal accumulation of collagen
spread through the section; grade 2, an increase in collagen in
an area consisting of between one third and two thirds of the
total width of the media or multiple small areas that together
could represent the same; grade 3, an increase of collagen in
an area comprising more than two thirds of the total width of
the media. These areas of medial damage are large, and col-
lagen is increased significantly. These criteria were used for
both the aorta and the pulmonary artery.
Medionecrosis. Defined as a focal loss of smooth muscle
cell nuclei in the media. It was graded at a magnification of
· 100 times. Three grades were recognized: grade 1, focal loss
of nuclei in an area consisting less than one third of the total
width of the media; grade 2, focal loss of nuclei in an area
consisting of one and two thirds of the medial thickness;
grade 3, focal loss of nuclei in an area comprising more than
two thirds of the total media thickness or batched areas that
together could represent the same.
Accumulation of mucoid material (cystic medial necrosis).
The mucoid material or mucopolysaccharides were observed
in the presence of intact elastic lamellae and in the presence
of fragmented elastic fibers; no cystic wall was ever identi-
fied. Three grades of accumulation of mucoid material were
defined at a magnification of · 100 times: grade 1, minute foci
of mucoid material (cysts) were present within a single lamel-
lar unit, not encompassing its entire width; grade 2, size or
number of cysts increased, and the mucoid material covered
the total width of 1 lamellar unit or equivalent areas (width)
in different regions of the media; grade 3, the cysts were large
and extended in area over more than 1 lamellar unit, either
because of focal aggregation of small cysts with intact elastic
lamellae or because of large cysts in an area with fragmented
elastic fibers forming pools of mucoid material.
Changes in the smooth muscle cells orientation. Because
changes in smooth muscle cell orientation are not always
associated with severe elastic fragmentation, this feature was
classified separately. These changes refer to different orienta-
tion of the cells so that the longitudinal aspect was not seen;
instead, a transverse view of the cells was observed. Three
grades were recognized at magnification of · 100 times: grade
1, small foci with change in the orientation of the smooth
muscle cells, which could be spread in different areas; grade
2, area with change in the smooth muscle cell orientation or
several areas that together represent between one third and
one half of the thickness of the media; grade 3, large area of
changes in the smooth muscle cell orientation, usually asso-
ciated with severe elastic fragmentation and consisting more
than one half of the media thickness, giving a very disorga-
nized appearance to the specimen that is used for both aorta
and pulmonary artery.
Elastic fragmentation. Defined as focal fragmentation of
elastic lamellae in the media of the aorta and pulmonary
artery. Because the quantitation and the organization of the
elastic tissue in the aorta differ from that in the pulmonary
artery, somewhat different criteria were used for fragmenta-
tion of elastic lamellae in these vessels. Magnification of
· 200 was used.
For the aorta. Grade 1: fewer than 5 foci of elastic lamella
fragmentation in 1 microscopic field, each focus comprising
2 to 4 neighboring elastic lamellae; interruption of 1 elastic
fiber was not interpreted as fragmentation. Grade 2: 5 or more
(less than 10) foci with elastic lamella fragmentation in 1
microscopic field, each focus consisting of 2 to 4 neighbor-
ing elastic lamellae; the foci could be confluent or scattered
throughout the media of the aorta. Grade 3: presence of foci
with elastic fragmentation in 10 or more neighboring elastic
lamellae, irrespective of the number of foci per microscopic
field; smooth muscle cells of the media usually showed alter-
ation in orientation.
For the pulmonary trunk. At any age, in an otherwise nor-
mal pulmonary artery, the elastic tissue is not a continuous
plate as it is in the aorta, even though it is easy to recognize
the units comprised of parallel elastic fibers, with smooth
muscle cells, collagen, and ground substance in between.
Grade 1: A small area with fragmented elastic tissue can be
seen and the smooth muscle cells do not show significant
change in the orientation. Grade 2: Some areas, comprising
between one third and one half of the medial thickness of the
pulmonary artery were unusually fragmented, which shows
an black point aspect of the elastic tissue or loss of paral-
lelism of the lamellar components. It is frequently associated
with focal orientation changes of the muscle cells. Grade 3:
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The elastin lamellae was severely fragmented, with the black
point aspect spread in the media thickness, and the identifica-
tion of the lamellar unit was not possible because of the
severe disorganization of the media.
Discussion
Dr Francis Robicsek (Charlotte, NC). This is a very inter-
esting and important paper which provides additional proof
that the aortic valve is not composed from leaflets alone but
from leaflets and adjoining sinuses. Although our observa-
tions are similar to those of the authors, we went 1 step fur-
ther. In our in vitro experiments, we have mounted normal
human aortic roots in a pulse duplicator. Using 500 frames
per second cinematography, as expected, we documented
beautiful aortic valve function, symmetrical and synchronous
leaflet opening and closure.
However, when we made the aortic wall stiff by spraying it
from the outside with plastic adhesive, aortic valve function
become highly irregular, asynchronous and asymmetric, and
the computer-measured stress overload on the leaflet became
highly significant. 
Do you think that the phenomenon you observed (ie, simul-
taneous changes in the aortic wall and leaflet) is not just ran-
dom occurrence but that the stiffening of the aortic wall itself
would cause secondary leaflet anomalies? 
Dr de Sa. We believe that changes in the ascending aorta
wall are not a consequence of the hemodynamic changes
alone. There are previous studies that show increased preva-
lence of aortic root dilation and aneurysm of the ascending
aorta in patients with normal function or mild dysfunction of
the bicuspid aortic valve. The turbulent flow causes degener-
ative changes in the aortic wall, but we have seen that, in
patients with bicuspid aortic valve disease, these degenerative
processes are worse. It means there is likely also an intrinsic
defect involving the ascending aorta and possibly the pul-
monary arterial walls. This may explain why these patients
come to surgical treatment earlier.
Dr David. As a coauthor, I should not be discussing this
paper, but I would like to make a couple of comments. The
histologic appearance of those pulmonary arteries was scary
for a surgeon who performs the Ross procedure using the full
root replacement technique. Dr de Sa found severe degenera-
tive changes in the pulmonary arterial wall of patients with
bicuspid and tricuspid aortic valves. The second remark I
would like to make is related to Dr Robicsek’s comments on
the interactions between leaflets and sinuses. The pulmonary
valves examined by Dr de Sa were entirely normal macro-
scopically, and yet their arterial wall had severe degenerative
changes.
Dr Timothy J. Gardner (Philadelphia, Pa). Do you think
that you should be able to find a specific gene defect? 
Dr David. Absolutely. I believe bicuspid aortic valve is an
inherited disorder and that the same gene is likely responsible
for the leaflets and the arterial wall abnormalities.
Dr Ronald C. Elkins (Oklahoma City, Okla). One of the
aspects of the study that we need to look at concerns patients
who have bicuspid aortic valve disease grouped into about 3
different groups of patients. There are those who have pure
aortic insufficiency with a bicuspid aortic valve and that enti-
ty is frequently associated, or more frequently associated,
with marked dilatation of their ascending aorta at the time
they come to surgical intervention because of problems asso-
ciated with their left ventricle. There is another group of
patients who have aortic stenosis who infrequently have
marked dilatation of their ascending aorta. And then, there is
a third group of patients who have no valvular heart disease,
other than a bicuspid aortic valve, who wind up with ascend-
ing aortic disease on occasions. The same is true for patients
with tricuspid valve. 
One of the things that we do not have in this article, which
would be very helpful, is any correlation between the clinical
presentation of the patient and the factors that are involved.
We have been very interested for a long period in trying to
document possible abnormalities in fibrillin and in elastin in
the pulmonary artery, particularly in those patients who have
dilatation of the ascending aorta; and it has taken us about 3
years to really get to the point that we could consistently use
a monoclonal antibody stain to identify fibrillin and elastin in
a specific fashion. 
We have now stained 39 ascending aortas that were associ-
ated with significant dilatation or aneurysm formation, and
we have stained 9 pulmonary arteries in these same patients.
In those 39 patients, our data identifies 3 distinct groups of
patients. There are those patients who have marked abnor-
malities in the elastin expression; there is a group of patients
that have essentially normal fibrillin and elastin expression,
and then there is a small group of patients that is an interme-
diary group. We have only identified 1 patient in the series
who had significant elastin expression abnormalities in the
pulmonary artery. 
I agree with Dr David that there are patients who will have
significant abnormalities in their pulmonary artery. Is it as
prevalent, as he would say, and what is the significance of the
findings that they have demonstrated to us in terms of clini-
cal presentation? Because we all know that irrespective of
what valve one puts in the aorta, many times the ascending
aorta goes on to considerable dilatation, and even to dissec-
tion, after an aortic valve replacement. What we need to iden-
tify is who are those patients and how do they differ from
those patients who have no abnormality in their ascending
aorta or pulmonary artery. 
Dr de Sa. We are also measuring fibrillin-1 in the ascend-
ing aorta and pulmonary artery in this group of patients. But
we have found that the histologic aspect in light microscopy
does not necessarily correlate with the molecular findings.
This means that, even in patients with significant cystic medi-
al necrosis and elastic fragmentation, the molecular analysis
of fibrillin-1 may not differ from controls. This is described
in previous studies about quantitative analyses in Marfan dis-
ease. This microfibrillar protein is not quantitatively reduced
in all cultures from Marfan specimens.
Unfortunately, these degenerative changes are part of a
variable and complex process, and many clinical factors
(such as age, hypertension, type of lesion, and metabolic dis-
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eases) could influence in these histologic findings. We have
not found a correlation between type of lesion, stenosis, or
regurgitation, but we have to recognize that the sample size is
very small and that we cannot generalize.
Dr Gino Gerosa (Padova, Italy). I enjoyed your presenta-
tion. After the Wheat studies of the late 1960s, we extensive-
ly reviewed the histologic appearance of the pulmonary artery
wall in comparison with the aortic counterpart. We know that,
in the absence of pulmonary hypertension, the pulmonary
artery wall will modify its aorta-like structure during fetal life,
which has elastic fibers that are long, uniform, and parallel, to
the so-called pulmonary-like configuration with elastic fibers
that are not anymore long, uniform, and parallel.
Did you compare the histologic findings of the pulmonary
artery wall and the aortic wall from the same heart? 
Do you agree with the concept that probably the best indica-
tion for the Ross procedure, irrespective of the bicuspid aortic
valve presence, is for neonates and infants before the modifica-
tion of the pulmonary artery histologic configuration will occur? 
Dr de Sa. We collected both aorta and pulmonary artery
walls from 12 patients with bicuspid aortic valve disease and
from 9 patients with trileaflet aortic valve disease. Sixty-
seven percent of the patients in the bicuspid group and 81%
of patients in the trileaflet group had the same grade of cystic
medial necrosis in the ascending aorta and pulmonary trunk,
whereas the others had only 1 grade difference between the 2
vessels. This was the only histologic finding in which we
have found a correlation.
The oxygen saturation may be related in some way to the
histologic changes, and we may keep the pulmonary artery
histologic features if we expose this tissue to a very high oxy-
genation. But these degenerative processes are correlated
with other factors like pressure, flow, metabolic factors, and
genetic factors. I cannot answer whether a child with other
congenital malformation would have a normal molecular and
histologic formation of these vessels. Theoretically, after the
birth, the pulmonary trunk wall, which is thicker and more
organized, may have a more appropriate function as a sys-
temic valve or conduit, but we do not have experience with
Ross procedure in infants or neonates.
